Novartis Ag

Siemens Aktiengesellschaft

Ji Yue Zhang

Yuan Mi

Zhengtian Yu

Xingnian Fu

Feng He

Yao-Chang Xu

Yue Ping Li

Lei Liu

Lei Jiang

Fang Liang

Miao Dai

Guoliang Xun

Martin Sendzik

Lei Li

Ling Li

Qiong Zhang

Long Wang

Wei Qi

Hailong Zhang

Xiang-Ju Justin Gu

Ho Man Chan

Yongfeng Sun

Man Zhang

Kehao Zhao

Xiaoxia Yan

Chao Chen

Wei Chen

Yue Zhuo

Julien Papillon

Haibing Guo

Hongping Yu

Haibing Deng

Michael Dore

Xing Yi

Huixin Wan

Counde Oyang

Xuan Dai

Kun Chin Liu

Ying Huang

Sing Yeung Frankie Mak

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R, Rand Rare as defined herein.

Triazolopyridine compounds and uses thereof

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R, R, R, and Rare as defined herein.

Imidazolepyridine compounds and uses thereof

In an embodiment, an arc light sensor includes: a first polarizer, a second polarizer, a magneto-optical material, a first light filter and a processing unit. The first polarizer is used for polarizing incident first target light, to form first polarized light in a first polarization direction. The second polarizer is used for polarizing incident second target light, to form second polarized light in the first polarization direction. The magneto-optical material, in a current magnetic field, uses the current magnetic field to rotate a polarization direction of the first polarized light, to form third polarized light. The first light filter is used for filtering the third polarized light, to form fourth polarized light capable of passing in a second polarization direction. The processing unit is used for determining whether the second target light is arc light according to intensity of the second polarized light and intensity of the fourth polarized light.

Arc light sensor and arc light detection method

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Triazolopyridine compounds

Heterocyclic oxime compounds

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I). 

Heterocyclic hydrazone compounds

Growing community of inventors

Shanghai, China

Ji Yue Zhang